Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Beacon Roofing (BECN) Posts Narrower Q2 Loss, Beats On Sales

Published 05/07/2019, 10:27 PM
Updated 07/09/2023, 06:31 AM

Beacon Roofing Supply, Inc. (NASDAQ:BECN) reported better-than-expected results in second-quarter fiscal 2019. The top and bottom lines improved from the prior-year period, backed by positive organic growth, increased daily sales, aggressive cost-control measures, alongside solid price-cost performance during the reported quarter. Consequently, shares of the nations’ largest publicly traded distributor of roofing materials and complementary building products company grew nearly 2% in the after-hour trading session, following the earnings release.

Beacon Roofing reported adjusted loss of 45 cents per share, which is narrower than the Zacks Consensus Estimate of a loss of 51 cents by 11.8%. Also, the reported figure narrowed 28.6% from a loss of 35 cents per share a year ago. The upside was primarily attributable to strong sales in the markets that were less affected by inclement weather and lower operating expense, partially offset by pressurized gross margins.

Beacon Roofing Supply, Inc. Price, Consensus and EPS Surprise

Net sales of $1.43 billion topped the consensus mark of $1.39 billion by 3% and grew 0.2% year over year. The improvement was backed by highly attractive markets served by the company, along with steady repair & remodeling activity.

Segment & Operating Details

Sales in the Residential roofing product segment increased 2.9% to $598.9 million, while that of Non-residential roofing product unit decreased 5.7% from a year ago to $313.6 million. Complementary products’ sales of $516.5 million rose 1.1% year over year.

However, existing markets sales declined 0.4% from the prior-year quarter as a result of poor weather conditions. Nonetheless, the same metric climbed 1.2% year over year on the basis of business day.

Cost of goods sold (accounting for 76.6% of net sales) totaled $1,094 million, increasing 0.1% year over year. Gross margin contracted 30 basis points (bps) to 23.4%.

Operating expenses decreased 60 bps to 27.2% of total net sales during the quarter. Resultantly, its operating losses narrowed 30 bps from the prior-year quarter to 3.8% of net sales. However, adjusted EBITDA margin contracted 30 bps to 1.9%.

Cash Position

As of Mar 31, 2019, Beacon Roofing had cash and cash equivalents of $0.6 million, down from $16 million reported in the corresponding period of 2018. Cash used in operations were $242.1 million in the first six months of fiscal 2019 versus cash provided by operations of $40 million a year ago.

2019 Guidance Reiterated

For fiscal 2019, the company projects total sales in the range of $7-$7.35 billion. Organically, sales are anticipated to grow in the mid-single-digit range.

Adjusted EBITDA is expected in the range of $540-$610 million. Adjusted earnings per share are likely to be at the lower end of the previously expected range of $2.90-$3.35. Free cash flow is expected in the $200-$300 million range.

Zacks Rank and Stocks to Consider

Beacon Roofing currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Some better-ranked stocks in the Zacks Retail-Wholesale sector include Williams-Sonoma, Inc. (NYSE:WSM) , Build-A-Bear Workshop, Inc. (NYSE:BBW) and Ethan Allen Interiors Inc. (NYSE:ETH) , each carrying a Zacks Rank #2 (Buy).

Williams-Sonoma and Build-A-Bear have a three-five year expected EPS growth rate of 7.2% and 9%, respectively.

Ethan Allen's EPS growth rate for the current year is expected to be 17.8%.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


Beacon Roofing Supply, Inc. (BECN): Free Stock Analysis Report

Williams-Sonoma, Inc. (WSM): Free Stock Analysis Report

Ethan Allen Interiors Inc. (ETH): Free Stock Analysis Report

Build-A-Bear Workshop, Inc. (BBW): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.